Mirova US’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Sell
28,979
-4,887
-14% -$428K 0.03% 43
2026
Q1
$2.89M Sell
33,866
-62
-0.2% -$5.53K 0.03% 40
2025
Q4
$2.68M Buy
33,928
+5,434
+19% +$426K 0.03% 42
2025
Q3
$2.28M Buy
28,494
+9,614
+51% +$820K 0.02% 36
2025
Q2
$1.72M Buy
18,880
+2,769
+17% +$253K 0.02% 35
2025
Q1
$1.51M Buy
16,111
+4,262
+36% +$382K 0.02% 32
2024
Q4
$1.08M Buy
11,849
+1,659
+16% +$158K 0.01% 32
2024
Q3
$1.06M Buy
+10,190
New +$1.04M 0.01% 32
2023
Q3
Sell
-2,622
Closed -$202K 28
2023
Q2
$202K Buy
+2,622
New +$203K ﹤0.01% 27
2023
Q1
Sell
-2,545
Closed -$201K 28
2022
Q4
$201K Buy
+2,545
New +$191K ﹤0.01% 31
2022
Q3
Sell
-2,592
Closed -$207K 30
2022
Q2
$207K Buy
+2,592
New +$203K ﹤0.01% 28

Other funds holding CL

Mirova US's CL Position: Q2 2026 in Review

Mirova US reduced its Colgate-Palmolive (CL) stake by 14% in Q2 2026, selling an estimated $428K and leaving 28,979 shares worth $2.66M. The position accounts for 0.03% of the portfolio, ranked #43.

Mirova US first reported a position in CL in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.89M in Q1 2026. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Mirova US held 28,979 shares of Colgate-Palmolive worth $2.66M as of Q2 2026.
  • Mirova US sold 4,887 Colgate-Palmolive shares in Q2 2026, an estimated $428K.
  • Colgate-Palmolive made up 0.03% of Mirova US's portfolio in Q2 2026, its #43 holding.
  • Mirova US first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 11 quarters since.
  • Mirova US's Colgate-Palmolive position peaked at $2.89M in Q1 2026.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Mirova US's 13F filing for Q2 2026, filed 14 Aug 2026.